ACM
GBT

AlphaCrest Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

AlphaCrest Capital Management’s Portfolio GBT Stock Details GBT Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
2022
Q2 		$320K Buy
2022
Q1 		– Sell
2021
Q4 		$267K Sell
2021
Q3 		$434K Sell
2021
Q2 		$876K Buy
2020
Q3 		– Sell
2020
Q2 		$278K Sell
2020
Q1 		$383K Buy
2019
Q4 		– Sell
2019
Q3 		$277K Buy